Human Immunodeficiency Virus type 1 in seronegative infants born to HIV-1-infected mothers
Virology Journal volume 3, Article number: 52 (2006)
Some individuals repeatedly exposed to Human Immunodeficiency Virus do not seroconvert and are resistant to HIV infection. Here, in a pediatric cohort of HIV seronegative infants born of HIV-infected mothers, we have studied eight non-breastfed children in whom viral DNA was detected in their PBMC. Our objective was to assess whether silent infection in these children can be explained by the presence of integrated viral DNA.
The presence of viral DNA was corroborated by nested PCR with primers for gag and the nef/LTR regions of HIV-1. Integration of HIV DNA into the host genome was assessed by an Alu-LTR PCR. Amplicons were sequenced and phylogenetic analyzes were done.
HIV-1 DNA was detected in the earliest available PBMC sample from all eight infants, and two of them tested positive for HIV DNA at 2 years of age. Nested PCR resulted in the amplification of gag, nef/LTR and Alu-LTR fragments, which demostrated that HIV-1 DNA was integrated in the host cell genome. Each individual has a characteristic sequence pattern and is different from the LTR sequence of HXB2 prototype virus and other Mexican isolates.
HIV-1 DNA was observed in PBMC from HIV exposed seronegative children in this pediatric cohort.
Several studies have shown that some individuals repeatedly exposed to Human Immunodeficiency Virus Type 1 or its antigens are resistant to HIV infection [1–6]. Despite multiple exposures to HIV, several of these resistant subjects have no detectable anti-HIV IgG antibodies in serum but instead present high anti-HIV CD4+ cell lymphoproliferative activity and strong CD8 cell mediated antiviral responses [1, 2]. Other studies have described rare cases of HIV-1 exposed seronegative individuals (ES) in whom HIV DNA has been detected in peripheral blood cells by PCR. These exposed seronegative individuals include health care personnel with accidental percutaneous exposure to infected blood, sexual partners of known HIV-1-infected persons and infants born to HIV-1-infected mothers [3–6]. In case of the pediatric infections some of these children appear to have eliminated virus-infected cells , others continue to harbor cells with viral DNA for prolonged periods of time . These antibody-negative, HIV-1 DNA-positive children have also been called "silent pediatric infections".
In this study, we report silent pediatric infection in 8 children born from HIV-1-positive mothers. Viral DNA could be amplified from their PBMC but we observed no evidence of viral replication or anti-HIV IgG antibodies in serum.
To examine the potential presence of HIV DNA in seronegative children born to HIV-1-infected mothers of the Mexico City Reference and Diagnostic Unit HIV Pediatric Cohort, we selected 8 children on the basis of repeatedly negative virus culture and a positive HIV DNA PCR result in our laboratory. The children did not show any HIV/AIDS related symptoms and had never received antiretroviral treatment. Blood plasma HIV-1 RNA concentration (viral load) was negative in any children samples. Stored blood samples from each child were studied at different ages (Table 1). The study received approval of the Committee for Human Subject Research (Ministry of Health of México).
To detect HIV-1 sequences in PBMC, two nested polymerase PCR amplifications were used (GAG and nef/LTR). The initial amplification of DNA was performed using GAG1-GAG2 (5'TCCACCTATCCCAGTAGGAG3' and 5'GGTCGTTGCCAAAGAGTGAT3') or LTR1-LTR2 primers . An aliquot (5 μL) of first round PCR product was then used as a template in a second PCR reaction with GAG3-GAG4 (5'TAAAAGATGGATAATCCTGGG and 5'GCCAAAGAGTGATCTGAGGG3') or LTR3-LTR4 primers . Controls for contamination (DNA of seronegative children) and for sensitivity (10 HIV copies) was added in each experiment in order to exclude all non-sensitive experiments. Different rooms were used for DNA extraction, PCR-buffer preparation, amplification and electrophoresis. Amplicons were never transferred to the area reserved for unamplified sequences. Thus, we cannot attribute positive PCR results to contamination. To detect integrated HIV-1 DNA, 2 μg of DNA were subjected to amplification by Alu-LTR PCR , using the Alu primer and HIV-1 LTR primer LTR4. After Alu-LTR PCR, a second round of PCR was performed with an aliquot equivalent to 1/10 of the PCR products using LTR specific primer pair LTR3-UIRH4 (Fig 1). To examine the LTR/nef region, PCR amplicons of the second round (LTR3-LTR4) were sequenced .
Phylogenetic relationships were determined using the MEGA2 versión 3.1 software package. A Phylogenetic tree was constructed by the neighbor-joining method and tree was bootstrapped with 100 replications. We used the Kimura two-parameter model to calculate sequence variation within the LTR sequences.
Detection of HIV-1 DNA in exposed seronegative children
HIV-1 DNA was detected by the amplification of GAG and LTR fragments (Fig. 1). Based on these results, two groups of patients were observed: in the first group (children P1 and P5), persistent detection of both fragments (GAG and LTR) in sequential samples were detected; in the second group (children P2, P3, P4, P6, P7 and P8), in whom GAG and LTR fragments were detected in early samples, these viral genes were not detected in subsequent samples.
Integration of the HIV-1 genome detected in exposed seronegative children
All the PBMC samples with a positive gag and LTR fragment amplification also resulted in amplification of the Alu-LTR binding sequence (Fig. 1). These results confirmed the presence of HIV DNA and indicated that the viral DNA detected in the children was integrated into the host genome. Additionally total mRNA was extracted from PBMC and HIV-1 mRNA transcripts were amplified by reverse-transcriptase PCR (data not shown). The complete or unprocessed mRNA was not detected in any children samples.
nef/LTR sequences of eight children have a characteristic sequence pattern
The nef/ LTR regulatory region sequence in the proviral DNA of the children's cells was obtained and compared to that of HXB2 prototype virus and consensus sequences of clades of A, C, and E. All sequences were shown by phylogeny to be more similar to the consensus of clade B (Fig 2). Each individual has a characteristic sequence pattern and is different from the LTR sequence of HXB2 prototype virus and other Mexican isolates . Sequential analysis of nef/LTR sequences of samples of P1 and P2 children were done and Phylogenetic relationship were estimated. Sequences of sequential samples of P1 and P2 were grouped closely in the same cluster, supporting the closely relationship between these samples (fig 2). A variation of 4% was observed in the region overlapping the nef gene, between -295 and -121 bp. In contrast, the non-translated region, between -120 and +80 bp, presented a variation lower than 2%. These results are similar to data reported in other studies with AIDS patients .
Cases of children who appear to have eliminated HIV infection are rare as most of them reported are due to contamination in the PCR processes. Moreover, these previous studies analyzed only env sequences of viruses isolated from children with apparent silent infections and their seropositive mothers, and no phylogenetic relation was found among the isolates . In our study, the presence of the viral genome was confirmed by amplification of two different sequences in the conserved Gag/LTR regions of the virus. Additionally, PCR contamination in our study is improbable since DNA extraction, first and second round amplification and separation of PCR products by electrophoresis were performed in different areas. Negative control of DNA of Non-Infected PBMC was included in every reaction and no amplification was shown (Fig 1).
It is also unlikely that cells from the mother were being a source of contamination. It has been shown that the passage of infectious agents or cells to the fetus is rather limited . Even though there is some evidence that bidirectional traffic of cells, including leukocytes, may occur in human pregnancy , the frequency of such traffic determined was not consistent in previous studies . Furthermore, in a mouse model the maternal cells were undetectable after 9 days postpartum . In our case the earliest sample was taken at 3 month of age, and thus the presence of mother cells at this time in the children is improbable. Unfortunately It was not possible to analyze the sequence of the virus of the children's mothers in order to confirm relatedness. Nevertheless sequences of the nef/ LTR region of the viruses analyzed showed HIV genetic diversity in our cohort among the children and with other Mexican virus isolates . Additionally we demonstrate phylogenetic relationship between the sequential samples of two children P1 and P2. This agrees with the amplification of proviral DNA that comes from the subject, and makes less likely the possibility of contamination.
Our results indicate that the seronegative children studied here were exposed to HIV and had cells with proviral HIV. The particularly long period of time of detection of the viral genome suggests that proviral HIV can be present in cells with a very long half-life, probably in resting CD4+ T cells that keep HIV suppressed. Moreover we find no evidence of active or productive infection consistent of HIV viral load negative results and no detection of unspliced HIV RNA (data not shown) in any children sample. This indicates the possibility of dead end infection in patients that loose proviral DNA. These results suggests an extends revision in molecular diagnostic of HIV children infection specific in PCR of HIV DNA from peripheral blood mononuclear cell (PBMC), and detection of virus by PBMC co-culture in peripheral blood from the infant.
Shearer GM, Clerici M: Protective immunity against HIV infection: has nature done the experiment for us. Immunol Today 1996, 17: 21-24. 10.1016/0167-5699(96)80564-0
Beretta A, Weiss SH, Rappocciolo G, Clerici M: Human immunodeficiency virus type 1 (HIV-1) seronegative infection drug users at risk for HIV exposure have antibodies to HLA class I antigens and T cells specific for HIV envelope. J Inf Dis 1996, 173: 472-476.
Roques PA, Gras G, Parnet Mathieu F, Mabondzo AM, Dollfus C, Narwa R, Marcé D, Tranchot-Diallo J, Hervé F, Lasfargues G, Courpotin C, Dormont D: Clearance of HIV infection in 12 perinatally infected children: clinical, virological and immunological data. AIDS 1995, 9: F19-F26.
Newell ML, Dunn D, De Maria A, Ferrazin A, De Rossi A, Giaquinto C, Levy J, Alimenti A, Ehrnst A, Bohlin AB, Ljung R, Peckman C: Detection of virus in vertically exposed HIV-antibody negative children. Lancet 1996, 347: 213-215. 10.1016/S0140-6736(96)90401-8
Zhu T, Corey L, Hwangbo Y, Lee JM, Learn GH, Mullins JI, McElrath MJ: Persistence of Extraordinarily Low Levels of Genetically Homogeneous Human Immunodeficiency Virus Type 1 in Exposed Seronegative Individuals. J Virol 2003, 77: 6108-6116. 10.1128/JVI.77.11.6108-6116.2003
Koning F, van der Vorst TJ, Schuitemaker H: Low Levels of Human Immunodeficiency Virus Type 1 DNA in High-Risk Seronegative Men. J Virol 2005, 79: 6551-6553. 10.1128/JVI.79.10.6551-6553.2005
Gómez Román VR, Vázquez JA, Basualdo MC, Estrada FJ, Ramos-Kuri M, Soler C: nef/Long terminal repeat quasispecies from HIV type 1 infected Mexican patients with different progression patterns and their pathogenesis in hu-PBL-SCID Mice. AIDS Res Hum Retroviruses 2000, 16: 441-452. 10.1089/088922200309106
Wu Y, Marsch JW: Selective Transcription and modulation of resting T cell activity by preintegrated HIV DNA. Science 2001, 293: 1503-1506. 10.1126/science.1061548
Zhang L, Huang Y, Yuan H, Chen BK, James IP, Ho DD: Genotypic and phenotypic characterization of long terminal repeat sequences from long-term survivors of human immunodeficiency virus type 1 infection. J Virol 1997, 71: 5608-5613.
Frenkel LM, Mullins JI, Learn GH, Manns-Arcuino L, Herring BL, Kalish ML, Steketee RW, Thea DM, Nichols JE, Liu SL, Harmache A, He X, Muthui D, Madan A, Hood L, Haase AT, Zupancic M, Staskus K, Wolinsky S, Krogstad P, Zhao J, Chen I, Koup R, Ho D, Roberts NJ Jr: Genetic Evaluation of Suspected Cases of Transient HIV-1 Infection of Infants. Science 1998, 280: 1073-1076. 10.1126/science.280.5366.1073
Tscherning-Casper C, Papadogiannakis N, Anvret M, Stolpe L, Lindgren S, Bohlin AB, Albert J, Fenyo EM: The trophoblastic epithelial barrier is not infected in full-term placentae of human immunodeficiency virus-seropositive mothers undergoing antiretroviral therapy. J Virol 1999, 73: 9673-8.
Papadogiannakis N: Traffic of leukocytes through the materno fetal placental interface and its possible consequences. Curr Top Microbiol Immunol 1997, 222: 141-57.
Zhou L, Yoshimura Y, Huang Y, Suzuki R, Yokohama M, Okabe M, Shimamura M: Two independent pathways of maternal cell transmission to offspring: through placenta during pregnancy and by breast-feeding after birth. Immunol 2000, 101: 570-581. 10.1046/j.1365-2567.2000.00144.x
We thank the present and previous members of the laboratory for helpful suggestions and for expert technical assistance, Isabel Pérez Monfort for help in preparing the manuscript, and Enrique Espinosa for careful reading and critical review of this manuscript. Funding for this research was provided by the Mexican Ministry of Health. VPJA (138542) was recipients of CONACYT fellowships.
The author(s) declare that they have no competing interests.
Gudiño Rosales JC helped to carried out the molecular genetic studies. Basualdo Sigales MC carried out the virus culture of the Mexico City Reference and Diagnostic Unit HIV Pediatric Cohort. Reyes Teran G. participated in the design of the study. Soler C. conceived of the study, and participated in its design and coordination and helped to draft the manuscript. Vazquez Perez JA carried out the molecular genetic studies, participated in design of the study and coordination and drafts the manuscript. All authors read and approved the final manuscript.
About this article
Cite this article
Pérez JA, V., Sigales MC, B., G, RT. et al. Human Immunodeficiency Virus type 1 in seronegative infants born to HIV-1-infected mothers. Virol J 3, 52 (2006). https://doi.org/10.1186/1743-422X-3-52